KennethB.GordonMD

Professor and Chair, Department of Dermatology Medical College of Wisconsin

Dr. Gordon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10000 W Bluemound Rd
Wauwatosa, WI 53226
Phone+1 414-454-8000

Fax+1 414-805-3888

McGaw Medical Center of Northwestern UniversityResidency, Dermatology, 1993 - 1996
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1990 - 1993
Columbia University Vagelos College of Physicians and SurgeonsClass of 1990

PubMed

Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
Andrew Blauvelt, Kenneth B Gordon, Richard G Langley, Patrick J Branigan, Yanqing Chen
The Journal of Investigative Dermatology. 2024-12-01
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?
Nicole D Boswell, Shikha Singla, Kenneth B Gordon
American Journal of Clinical Dermatology. 2024-09-01
1 citations
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.
Kenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, Laura C Coates, Filip E Van den Bosch
Dermatology and Therapy. 2024-09-01

Bimzelx Shows Consistent Safety Profile Compared with Similar Psoriasis TreatmentsJune 14th, 2022
Risankizumab Shown to Be Safe over the Long TermMarch 18th, 2022